Empirical Asset Management’s Franklin Systematic Style Premia ETF FLSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$320K Buy
11,185
+1,489
+15% +$42K 0.07% 306
2026
Q2
$268K Sell
9,696
-40
-0.4% -$1.09K 0.06% 338
2026
Q1
$265K Buy
9,736
+1,247
+15% +$33.8K 0.07% 315
2025
Q4
$228K Sell
8,489
-8,554
-50% -$229K 0.06% 302
2025
Q3
$452K Sell
17,043
-27,627
-62% -$694K 0.13% 244
2025
Q2
$1.08M Buy
44,670
+2,675
+6% +$64.8K 0.33% 82
2025
Q1
$1.03M Buy
41,995
+3,712
+10% +$89.1K 0.35% 73
2024
Q4
$915K Buy
38,283
+725
+2% +$17.4K 0.3% 96
2024
Q3
$905K Buy
37,558
+26,535
+241% +$632K 0.32% 87
2024
Q2
$261K Buy
+11,023
New +$261K 0.1% 271

Other funds holding FLSP

Empirical Asset Management's FLSP Position: Q3 2026 in Review

Empirical Asset Management increased its Franklin Systematic Style Premia ETF (FLSP) stake by 15% in Q3 2026, buying an estimated $42K and bringing the position to 11,185 shares worth $320K. The position accounts for 0.07% of the portfolio, ranked #306.

Empirical Asset Management first reported a position in FLSP in Q2 2024 and has held it in 10 quarters since. The position peaked at $1.08M in Q2 2025. 84 funds tracked by Wall St. Rank hold FLSP as of Q3 2026.

  • Empirical Asset Management held 11,185 shares of Franklin Systematic Style Premia ETF worth $320K as of Q3 2026.
  • Empirical Asset Management bought 1,489 Franklin Systematic Style Premia ETF shares in Q3 2026, an estimated $42K.
  • Franklin Systematic Style Premia ETF made up 0.07% of Empirical Asset Management's portfolio in Q3 2026, its #306 holding.
  • Empirical Asset Management first reported a position in Franklin Systematic Style Premia ETF in Q2 2024 and has held it in 10 quarters since.
  • Empirical Asset Management's Franklin Systematic Style Premia ETF position peaked at $1.08M in Q2 2025.
  • 84 funds tracked by Wall St. Rank held Franklin Systematic Style Premia ETF as of Q3 2026.

Based on Empirical Asset Management's 13F filing for Q3 2026, filed 12 Nov 2026.